Series C funding round for Colossal Biosciences raising $200M in January 2025
Series C funding round for Colossal Biosciences raising $200M in January 2025
| Investor | Firm Type | Partner |
|---|
TWG GlobalLEAD | Venture Capital | — |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Angel | Sven-Olof Lindblad | |
| Angel | Paul Tudor Jones | |
| Angel | Robert Nelsen | |
| Angel | Victor L. Vescovo | |
| Angel | Fran Walsh | |
| Angel | Tim Draper | |
| Angel | Jeff Wilke | |
| Angel | Giammaria Giuliani | |
| Angel | Peter Jackson | |
| Angel | Ric Edelman | |
| Angel | Brandon Fugal | |
| Angel | Richard Garriott |
This company has completed 7 funding rounds. Current round is highlighted.
Total Raised
$615M
Top Valuation
$10.2B
Colossal Biosciences raised $200M in a Series C round.
The round was announced on 01/01/25.
The round was led by Mark Walter.